Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Xenon Pharmaceuticals Inc. | Chief Commercial Officer | Stock Option (Right to Buy) | 100K | Mar 11, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
XENE | Xenon Pharmaceuticals Inc. | Mar 11, 2024 | 1 | $0 | 4 | Mar 12, 2024 | Chief Commercial Officer |
XENE | Xenon Pharmaceuticals Inc. | Mar 10, 2023 | 1 | $0 | 4 | Mar 14, 2023 | Chief Commercial Officer |
XENE | Xenon Pharmaceuticals Inc. | Mar 10, 2022 | 1 | $0 | 4 | Mar 14, 2022 | Chief Commercial Officer |
XENE | Xenon Pharmaceuticals Inc. | Dec 6, 2021 | 1 | $97.6K | 4 | Dec 7, 2021 | Chief Commercial Officer |